Author

Jack Ratchford

Institution: Genentech

Observed institution: Genentech

OpenAlex ID: A5008963890

A Double-masked, Placebo-controlled Study with Open-label Period to Evaluate the Efficacy and Safety of Inebilizumab in Adult Subjects with Neuromyelitis Optica Spectrum Disorders–Top line efficacy and safety results (Plen02.001)

2019 · Bruce Cree, Jeffrey Bennett, et al. · Neurology · 8

Evaluation Of Infusion Reactions And Infusion Times In The N-Momentum Study Of Inebilizumab For NMOSD (1941)

2021 · Mark Tullman, Jack Ratchford, et al. · Neurology · 3

Fenebrutinib Maintains Low Disease Activity in Relapsing Multiple Sclerosis: Results from the FENopta Trial Open-label Extension (P8-1.005)

2025 · Jiwon Oh, Jelena Drulovic, et al. · Neurology · 1

Works count: 3

Citation count: 12

H-index: 2

I10-index: